Mindray Hematology Solution Helps High-Volume Lab Run 2,820,000 CBC Tests Annually
By LabMedica International staff writers Posted on 20 Oct 2020 |

Image: Mindray Hematology Solution Helps High-Volume Lab Run 2,820,000 CBC Tests Annually (Photo courtesy of Mindray)

Image: The customized Mindray CAL 8000 automation lines help the lab improve workflow and reduce manual handling (Photo courtesy of Mindray)

Image: Routes optimisation - Regular design and sample route (Photo courtesy of Mindray)

Image: Routes optimisation - Customized design and sample route(Photo courtesy of Mindray)
High-volume laboratories face several challenges, including high instrument failure rate, errors due to several manual steps, low efficiency and long TAT, and heavier workload for the lab staff.
Mindray’s (Shenzhen, China) hematology solutions can help labs face these challenges such as its tailor-made solution provided for CientíficaLab (Sao Paulo, Brazil) that now helps the high-volume lab run 2,820,000 CBC tests annually.
Owned by one of the largest diagnostic laboratory chains in the world, CientíficaLab provides clinical analysis service to 26 hospitals and 883 outpatient units in the Brazil public sector. Prior to its recent partnership with Mindray, CientíficaLab used to perform all its blood tests on more than a dozen stand-alone analyzers and slide makers, which were low in efficiency and demanded significant manpower. With overwhelming workload, the laboratory staff had to work extremely long hours, with three shifts a day, six days a week. High failure rate of the old instruments posed another daunting challenge for CientíficaLab, often resulting in extensive downtime.
After studying the laboratory’s challenges, Mindray came up with a tailor-made hematology automation solution for CientíficaLab. To automate its workflow and improve productivity, Mindray replaced the old stand-alone instruments with two high performance CAL 8000 Cellular Analysis Lines, each connecting four units of BC-6800Plus Auto Hematology Analyzers and one unit of SC-120 Auto Slide Maker and Stainer. Equipped with the labXpert data analysis software, the automation lines automatically validate test results and perform rerun and retest of abnormal hematology samples as per pre-defined rules. This helped reduce the laboratory's manual work substantially and improve its Standard Operating Procedures (SOPs).
After tracking the laboratory’s working path of samples, from collection to testing to microscopic analysis, Mindray provided a customized solution – placing the two automation lines face-to-face, but re-configuring one of them to make its sample route in the same direction as the other. This special design now enables just one technician to easily handle large amount of samples on both lines at the same time creating the shortest, most time-saving route from sample loading to unloading, all the way to microscopic review and result delivery.
During onsite inspection, Mindray discovered another possibility of helping CientíficaLab optimize its workflow. Before installing CAL 8000, the laboratory technicians had to print out the test result of the abnormal sample, and then bring the result along with the slide to the microscopy area for result comparison. These paper documents will be filed away for five years, managing which will be a demanding task. Mindray helped digitalize the process by installing the labXpert software at the microscopy area which allows data transfer and storage within the laboratory information system. Simply by scanning the barcode on the slides, technicians can now easily access the information of the test results during microscopic analysis.
Higher stability and reliability of the CAL 8000 system have also brought significant benefits for CientíficaLab in terms of enhanced efficiency and faster TAT. The laboratory used to have 11 stand-alone instruments that always had breakdown issues, with uptime of only around 60% to 70%. CientíficaLab had to wait for engineers to repair or spare parts to be sent which could take days and significantly impacted daily routine. The introduction of CAL 8000 with its reliability and stability has been a gift for the laboratory. Mindray analyzers rarely see any failure issues which are resolved on the very same day or no later than the next day by the company or its local distributor.
With the introduction of the two customized CAL 8000, CientíficaLab has achieved significant improvement in both production capacity and cost-effectiveness. With the full capacity of just one CAL 8000 being superior to the previous 11 instruments operated by CientíficaLab and two Mindray automation lines working in good condition, there has been a huge improvement in the lab’s performance. Today, CientíficaLab’s headquarters alone performs 3,000,000 different tests per month, with up to 9,000 hematology tests each day – totaling nearly 2,820,000 a year.
“With the introduction of CAL 8000, we have increased our testing capacity,” said Fabiana Gomes Lancelotti, Hematology Department Supervisor at CientíficaLab. “The SC-120 Slide Maker and Stainer makes slides for microscopic analysis, then the results will be automatically validated and ready to report.”
“By placing one CAL 8000 face-to-face with the other, and adjusting the sample routes in the same direction, we can reduce the number of staff and make the process much simpler. Our productivity has improved by 50%,” said Audrei Roberto Bertini, Production Manager at CientíficaLab.
Related Links:
Mindray
Mindray’s (Shenzhen, China) hematology solutions can help labs face these challenges such as its tailor-made solution provided for CientíficaLab (Sao Paulo, Brazil) that now helps the high-volume lab run 2,820,000 CBC tests annually.
Owned by one of the largest diagnostic laboratory chains in the world, CientíficaLab provides clinical analysis service to 26 hospitals and 883 outpatient units in the Brazil public sector. Prior to its recent partnership with Mindray, CientíficaLab used to perform all its blood tests on more than a dozen stand-alone analyzers and slide makers, which were low in efficiency and demanded significant manpower. With overwhelming workload, the laboratory staff had to work extremely long hours, with three shifts a day, six days a week. High failure rate of the old instruments posed another daunting challenge for CientíficaLab, often resulting in extensive downtime.
After studying the laboratory’s challenges, Mindray came up with a tailor-made hematology automation solution for CientíficaLab. To automate its workflow and improve productivity, Mindray replaced the old stand-alone instruments with two high performance CAL 8000 Cellular Analysis Lines, each connecting four units of BC-6800Plus Auto Hematology Analyzers and one unit of SC-120 Auto Slide Maker and Stainer. Equipped with the labXpert data analysis software, the automation lines automatically validate test results and perform rerun and retest of abnormal hematology samples as per pre-defined rules. This helped reduce the laboratory's manual work substantially and improve its Standard Operating Procedures (SOPs).
After tracking the laboratory’s working path of samples, from collection to testing to microscopic analysis, Mindray provided a customized solution – placing the two automation lines face-to-face, but re-configuring one of them to make its sample route in the same direction as the other. This special design now enables just one technician to easily handle large amount of samples on both lines at the same time creating the shortest, most time-saving route from sample loading to unloading, all the way to microscopic review and result delivery.
During onsite inspection, Mindray discovered another possibility of helping CientíficaLab optimize its workflow. Before installing CAL 8000, the laboratory technicians had to print out the test result of the abnormal sample, and then bring the result along with the slide to the microscopy area for result comparison. These paper documents will be filed away for five years, managing which will be a demanding task. Mindray helped digitalize the process by installing the labXpert software at the microscopy area which allows data transfer and storage within the laboratory information system. Simply by scanning the barcode on the slides, technicians can now easily access the information of the test results during microscopic analysis.
Higher stability and reliability of the CAL 8000 system have also brought significant benefits for CientíficaLab in terms of enhanced efficiency and faster TAT. The laboratory used to have 11 stand-alone instruments that always had breakdown issues, with uptime of only around 60% to 70%. CientíficaLab had to wait for engineers to repair or spare parts to be sent which could take days and significantly impacted daily routine. The introduction of CAL 8000 with its reliability and stability has been a gift for the laboratory. Mindray analyzers rarely see any failure issues which are resolved on the very same day or no later than the next day by the company or its local distributor.
With the introduction of the two customized CAL 8000, CientíficaLab has achieved significant improvement in both production capacity and cost-effectiveness. With the full capacity of just one CAL 8000 being superior to the previous 11 instruments operated by CientíficaLab and two Mindray automation lines working in good condition, there has been a huge improvement in the lab’s performance. Today, CientíficaLab’s headquarters alone performs 3,000,000 different tests per month, with up to 9,000 hematology tests each day – totaling nearly 2,820,000 a year.
“With the introduction of CAL 8000, we have increased our testing capacity,” said Fabiana Gomes Lancelotti, Hematology Department Supervisor at CientíficaLab. “The SC-120 Slide Maker and Stainer makes slides for microscopic analysis, then the results will be automatically validated and ready to report.”
“By placing one CAL 8000 face-to-face with the other, and adjusting the sample routes in the same direction, we can reduce the number of staff and make the process much simpler. Our productivity has improved by 50%,” said Audrei Roberto Bertini, Production Manager at CientíficaLab.
Related Links:
Mindray
Latest Industry News
- Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
- Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
- New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
- Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
- Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration
- Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
- Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
- Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy
- CACLP 2025 Unites Global Innovators in IVD Industry
- Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
- ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- New Partnership Revolutionizes Analyses of Biological Samples
- Medlab Middle East Looks to The Future of Laboratories
- Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience
- bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics
Channels
Clinical Chemistry
view channel
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read moreMolecular Diagnostics
view channel
Liquid Biopsy Assay Detects Recurrence in CRC Patients Prior to Imaging
The detection of circulating tumor DNA (ctDNA) after treatment is a strong indicator of recurrence in colorectal cancer (CRC), but it often goes undetected due to the low traces of ctDNA present in the blood.... Read more
Ultra Fast Synovial Fluid Test Diagnoses Osteoarthritis and Rheumatoid Arthritis In 10 Minutes
Studies indicate that more than 50% of individuals aged 65 and older experience symptoms of osteoarthritis, while rheumatoid arthritis is a serious chronic condition affecting approximately 1 in 100 people... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read more
AI-Driven Analysis of Digital Pathology Images to Improve Pediatric Sarcoma Subtyping
Pediatric sarcomas are rare and diverse tumors that can develop in various types of soft tissue, such as muscle, tendons, fat, blood or lymphatic vessels, nerves, or the tissue surrounding joints.... Read more
AI-Based Model Predicts Kidney Cancer Therapy Response
Each year, nearly 435,000 individuals are diagnosed with clear cell renal cell carcinoma (ccRCC), making it the most prevalent subtype of kidney cancer. When the disease spreads, anti-angiogenic therapies... Read more
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read moreTechnology
view channel
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more